Search

27/03/2023 Amplified sinus-P-wave analysis predicts outcomes of cryoballoon ablation in patients with persistent and long-standing persistent atrial fibrillation: A multicentre study.
Creta A, Venier S, Tampakis K, Providencia R, Sunny J, Defaye P, Earley MJ, Finlay M, Hunter RJ, Lambiase PD, Papageorgiou N, Schilling RJ, Sporton S, Andrikopoulos G, Deschamps E, Albenque JP, Cardin C, Combes N, Combes S, Vinolas X, Moreno-Weidmann Z, Huang T, Eichenlaub M, Müller-Edenborn B, Arentz T, Jadidi AS, Boveda S. Amplified sinus-P-wave analysis predicts outcomes of cryoballoon ablation in patients with persistent and long-standing persistent atrial fibrillation: A multicentre study.. Frontiers in Cardiovascular Medicine. 2023; 10DOI:10.3389/fcvm.2023.1110165. PMID:37051067. IF:2.800(Q2/4D).
01/12/2025 Lipomatous metaplasia in cardiac CT: when 'normal' extracellular volume does not indicate myocardial viability - a case report
Pieszko, K, González, CR, Petracca, RL, Medel, DV. Lipomatous metaplasia in cardiac CT: when 'normal' extracellular volume does not indicate myocardial viability - a case report. European Heart Journal-Case Reports. 2025; 9(12)DOI:10.1093/ehjcr/ytaf612. PMID:41384087. IF:(Q/D).
27/11/2025 Protocol for the ELISPOT-TC Trial: A Randomized Controlled Study Evaluating CMV-Specific Cellular Immune Monitoring in Heart Transplant Recipients
García-Romero, E, Díez-Lopez, C, Kervella, D, Donoso, V, García-Cosío, MD, Ortiz-Bautista, C, Hernández-Pérez, FJ, Couto-Mallon, D, González-Vílchez, F, De La Fuente-galán, L, Lopez-Lopez, L, Grande-Trillo, A, Gomez-Molina, M, Catalá, P, Herrador, L, Rosenfeld, L, Ibáñez, S, Donadeu, L, Sabé, N, Comín-Colet, J, Bestard, O, González-Costello, J. Protocol for the ELISPOT-TC Trial: A Randomized Controlled Study Evaluating CMV-Specific Cellular Immune Monitoring in Heart Transplant Recipients. TRANSPLANT INTERNATIONAL. 2025; 38DOI:10.3389/ti.2025.15565. PMID:41394517. IF:3.000(Q1/1D).
24/11/2025 Clinical Impact of In-Hospital Hemoglobin Decline Without Overt Bleeding After Transcatheter Aortic Valve Replacement
Avvedimento, M, Cepas-Guillén, P, Nuche, J, Ternacle, J, Urena, M, Alperi, A, Cheema, A, Veiga-Fernandez, G, Nombela-Franco, L, Vilalta, V, Esposito, G, Campelo-Parada, F, Idolfi, C, del Trigo, M, Munoz-Garcia, A, Asmarats, L, Regueiro, A, del Val, D, Auffret, V, Melon, NM, Bonnet, G, Jonveaux, M, Mesnier, J, Avanzas, P, Rezaei, E, Fradejas-Sastre, V, Tirado-Conte, G, Fernández-Nofrerias, E, Franzone, A, Guitteny, T, Sorrentino, S, Oteo, JF, Gutiérrez-Alonso, L, Flores-Umanzor, E, Alfonso, F, Nolf, M, Côté, M, Pelletier-Beaumont, E, Rodés-Cabau, J. Clinical Impact of In-Hospital Hemoglobin Decline Without Overt Bleeding After Transcatheter Aortic Valve Replacement. JACC-Cardiovascular Interventions. 2025; 18(22)DOI:10.1016/j.jcin.2025.10.004. PMID:41297987. IF:11.400(Q1/1D).